戻る Agenda
Session 1 Official Opening
Session Chair(s)
Clare Lavery, MSC
Pharmacovigilance Excellence Principal
AstraZeneca, United Kingdom
Nick Sykes, MS
Policy Advisor, Regulatory Strategy
EFPIA, Belgium
Co-Chairs will welcome delegates to the Workshop outlining the importance of the discussion and the aims of the two day Workshop. This will also include a keynote speech covering the role of Clinical Trials in fostering good health and supporting new technologies.
Speaker(s)
Keynote Speech
Nick Sykes, MS
EFPIA, Belgium
Policy Advisor, Regulatory Strategy
Clare Lavery, MSC
AstraZeneca, United Kingdom
Pharmacovigilance Excellence Principal
Key Note Speech - Regulation of the European Parliament and the Council No 536/2014 on clinical trials – responding to challenges, fostering innovation
Lidia Retkowska-Mika, LLM
Office For Registration of Med. Products, Medical Devices and Biocides, Poland
Director Legal DPT